
A smaller outbreak of monkeypox is being documented across the world, as several countries, including the US and some in Europe, have continued to report new cases of the viral infection.
A few different names have come up repeatedly in these reports – Jynneos, Imvanex, and Imvamune – depending on where one is located in the world. They all refer back to the same thing: the only approved monkeypox vaccine in the world, which has been developed by Danish biotech firm Bavarian Nordic.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app